In silico profiling of miRNAs and their target polymorphisms in leukemia associated genes

Single Nucleotide Polymorphisms (SNPs) within microRNA (miRNA) encoding regions of the genome are a large potential source for biologically relevant variation. SNPs along with miRNA act as a powerful tool to study the biology of a disease and also have the potential in monitoring disease prognosis and diagnosis. Therefore, evaluating the functional role of target mRNA will be a major challenge of future studies in the field of cancer biomarker research in leukemia. To assess, whether miRNA target SNPs are implicated in leukemia associated genes, we conducted an in silico approach along with the availability of publicly available web based tools for miRNA prediction and comprehensive genomic databases of SNPs. In this in-depth report, we attempted to use two computational approaches: prediction of miRNA in leukemia associated genes, and identifying the functional role of mRNAs targeted by miRNA. Our results from this study suggest that the application of in silico algorithms miRdSNP, PupaSuite and UTRScan analyses might provide an alternative approach to select target untranslated region (UTR) SNPs and understand the effect of SNPs on the functional attributes or molecular phenotype of a protein

Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?

For centuries, itch was categorized as a submodality of pain. Recent research over the last decade has led to the realization that itch is in fact a separate and distinct, albeit closely related, sensation. Chronic itch is a common complaint and has numerous etiologies. Various receptors (TRPA1, TRPV1, PAR2, gastrin-releasing peptide receptor (GRPR), Mas-related G proteins), secreted molecules (histamine, nerve growth factor (NGF), substance P (SP), proteases), and cytokines/chemokines (thymic stromal lymphopoietin (TSLP), IL-2, IL-4, IL-13, and IL-31) are implicated as mediators of chronic pruritus. While much remains unknown regarding the mechanisms of chronic itch, this much is certain: there is no singular cause of itch. Rather, itch is caused by a complex interface between skin, keratinocytes, cutaneous nerve fibers, pruritogenic molecules, and the peripheral and central nervous systems. Atopic dermatitis is one of the most itchy skin dermatoses and affects millions worldwide. The sensation of atopic itch is mediated by the interplay between epidermal barrier dysfunction, upregulated immune cascades, and the activation of structures in the central nervous system. Clinicians are in possession of an arsenal of different treatment options ranging from moisturizers, topical immunomodulators, topical anesthetic ion channel inhibitors, systemic immunomodulators, as well as oral drugs capable of reducing neural hypersensitization. Emerging targeted therapies on the horizon, such as dupilumab, promise to usher in a new era of highly specific and efficacious treatments. Alternative medicine, stress reduction techniques, and patient education are also important treatment modalities. This review will focus on the mediators of chronic pruritus mainly associated with atopic dermatitis (atopic itch), as well as numerous different therapeutic options.No Full Tex